Selected research
Industry Research
Sequencing and Spatial Omics Platform Industry Research Report 2026
Market perspective
The global Sequencing and Spatial Omics Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Sequencing and Spatial Omics Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Sequencing and Spatial Omics Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Sequencing and Spatial Omics Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Sequencing and Spatial Omics Platform include Illumina, Thermo Fisher Scientific, PacBio, 10x Genomics, Element Biosciences, Ultima Genomics, Bruker Spatial Biology, Vizgen and Quanterix, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Sequencing and Spatial Omics Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Sequencing and Spatial Omics Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sequencing and Spatial Omics Platform Market by Company
Illumina
Thermo Fisher Scientific
PacBio
10x Genomics
Element Biosciences
Ultima Genomics
Bruker Spatial Biology
Vizgen
Quanterix
Standard BioTools
Oxford Nanopore Technologies
QIAGEN
Miltenyi Biotec
MGI Tech
STOmics
Novogene
Biomarker Technologies
SeekGene
Takara Bio
Rhelixa
Sequencing and Spatial Omics Platform Segment by Type
Single-Omics Platform
Multi-Omics Integration Platform
Others
Sequencing and Spatial Omics Platform Segment by Application
Biomedicine
Clinical Diagnosis
Agriculture and Animal and Plant Breeding
Others
Sequencing and Spatial Omics Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sequencing and Spatial Omics Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sequencing and Spatial Omics Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sequencing and Spatial Omics Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Sequencing and Spatial Omics Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-Omics Platform
- Multi-Omics Integration Platform
- Others
Applications
- Biomedicine
- Clinical Diagnosis
- Agriculture and Animal and Plant Breeding
- Others
Companies covered
- Illumina
- Thermo Fisher Scientific
- PacBio
- 10x Genomics
- Element Biosciences
- Ultima Genomics
- Bruker Spatial Biology
- Vizgen
- Quanterix
- Standard BioTools
- Oxford Nanopore Technologies
- QIAGEN
- Miltenyi Biotec
- MGI Tech
- STOmics
- Novogene
- Biomarker Technologies
- SeekGene
- Takara Bio
- Rhelixa
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Sequencing and Spatial Omics Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Single-Omics Platform
- 2.2.3 Multi-Omics Integration Platform
- 2.2.4 Others
- 2.3 Sequencing and Spatial Omics Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biomedicine
- 2.3.3 Clinical Diagnosis
- 2.3.4 Agriculture and Animal and Plant Breeding
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Sequencing and Spatial Omics Platform Breakdown Data by Type
- 3.1 Global Sequencing and Spatial Omics Platform Historic Market Size by Type (2021-2026)
- 3.2 Global Sequencing and Spatial Omics Platform Forecasted Market Size by Type (2027-2032)
4 Sequencing and Spatial Omics Platform Breakdown Data by Application
- 4.1 Global Sequencing and Spatial Omics Platform Historic Market Size by Application (2021-2026)
- 4.2 Global Sequencing and Spatial Omics Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Sequencing and Spatial Omics Platform Market Perspective (2021-2032)
- 5.2 Global Sequencing and Spatial Omics Platform Growth Trends by Region
- 5.2.1 Global Sequencing and Spatial Omics Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Sequencing and Spatial Omics Platform Historic Market Size by Region (2021-2026)
- 5.2.3 Sequencing and Spatial Omics Platform Forecasted Market Size by Region (2027-2032)
- 5.3 Sequencing and Spatial Omics Platform Market Dynamics
- 5.3.1 Sequencing and Spatial Omics Platform Industry Trends
- 5.3.2 Sequencing and Spatial Omics Platform Market Drivers
- 5.3.3 Sequencing and Spatial Omics Platform Market Challenges
- 5.3.4 Sequencing and Spatial Omics Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Sequencing and Spatial Omics Platform Players by Revenue
- 6.1.1 Global Top Sequencing and Spatial Omics Platform Players by Revenue (2021-2026)
- 6.1.2 Global Sequencing and Spatial Omics Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global Sequencing and Spatial Omics Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Sequencing and Spatial Omics Platform Head Office and Area Served
- 6.4 Global Sequencing and Spatial Omics Platform Players, Product Type & Application
- 6.5 Global Sequencing and Spatial Omics Platform Manufacturers Established Date
- 6.6 Global Sequencing and Spatial Omics Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Sequencing and Spatial Omics Platform Market Size (2021-2032)
- 7.2 North America Sequencing and Spatial Omics Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Sequencing and Spatial Omics Platform Market Size by Country (2021-2026)
- 7.4 North America Sequencing and Spatial Omics Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Sequencing and Spatial Omics Platform Market Size (2021-2032)
- 8.2 Europe Sequencing and Spatial Omics Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Sequencing and Spatial Omics Platform Market Size by Country (2021-2026)
- 8.4 Europe Sequencing and Spatial Omics Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Sequencing and Spatial Omics Platform Market Size (2021-2032)
- 9.2 Asia-Pacific Sequencing and Spatial Omics Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Sequencing and Spatial Omics Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Sequencing and Spatial Omics Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Sequencing and Spatial Omics Platform Market Size (2021-2032)
- 10.2 South America Sequencing and Spatial Omics Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Sequencing and Spatial Omics Platform Market Size by Country (2021-2026)
- 10.4 South America Sequencing and Spatial Omics Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Sequencing and Spatial Omics Platform Market Size (2021-2032)
- 11.2 Middle East & Africa Sequencing and Spatial Omics Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Sequencing and Spatial Omics Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Sequencing and Spatial Omics Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Illumina
- 12.1.1 Illumina Company Information
- 12.1.2 Illumina Business Overview
- 12.1.3 Illumina Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.1.4 Illumina Sequencing and Spatial Omics Platform Product Portfolio
- 12.1.5 Illumina Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific Sequencing and Spatial Omics Platform Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 PacBio
- 12.3.1 PacBio Company Information
- 12.3.2 PacBio Business Overview
- 12.3.3 PacBio Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.3.4 PacBio Sequencing and Spatial Omics Platform Product Portfolio
- 12.3.5 PacBio Recent Developments
- 12.4 10x Genomics
- 12.4.1 10x Genomics Company Information
- 12.4.2 10x Genomics Business Overview
- 12.4.3 10x Genomics Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.4.4 10x Genomics Sequencing and Spatial Omics Platform Product Portfolio
- 12.4.5 10x Genomics Recent Developments
- 12.5 Element Biosciences
- 12.5.1 Element Biosciences Company Information
- 12.5.2 Element Biosciences Business Overview
- 12.5.3 Element Biosciences Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.5.4 Element Biosciences Sequencing and Spatial Omics Platform Product Portfolio
- 12.5.5 Element Biosciences Recent Developments
- 12.6 Ultima Genomics
- 12.6.1 Ultima Genomics Company Information
- 12.6.2 Ultima Genomics Business Overview
- 12.6.3 Ultima Genomics Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.6.4 Ultima Genomics Sequencing and Spatial Omics Platform Product Portfolio
- 12.6.5 Ultima Genomics Recent Developments
- 12.7 Bruker Spatial Biology
- 12.7.1 Bruker Spatial Biology Company Information
- 12.7.2 Bruker Spatial Biology Business Overview
- 12.7.3 Bruker Spatial Biology Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.7.4 Bruker Spatial Biology Sequencing and Spatial Omics Platform Product Portfolio
- 12.7.5 Bruker Spatial Biology Recent Developments
- 12.8 Vizgen
- 12.8.1 Vizgen Company Information
- 12.8.2 Vizgen Business Overview
- 12.8.3 Vizgen Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.8.4 Vizgen Sequencing and Spatial Omics Platform Product Portfolio
- 12.8.5 Vizgen Recent Developments
- 12.9 Quanterix
- 12.9.1 Quanterix Company Information
- 12.9.2 Quanterix Business Overview
- 12.9.3 Quanterix Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.9.4 Quanterix Sequencing and Spatial Omics Platform Product Portfolio
- 12.9.5 Quanterix Recent Developments
- 12.10 Standard BioTools
- 12.10.1 Standard BioTools Company Information
- 12.10.2 Standard BioTools Business Overview
- 12.10.3 Standard BioTools Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.10.4 Standard BioTools Sequencing and Spatial Omics Platform Product Portfolio
- 12.10.5 Standard BioTools Recent Developments
- 12.11 Oxford Nanopore Technologies
- 12.11.1 Oxford Nanopore Technologies Company Information
- 12.11.2 Oxford Nanopore Technologies Business Overview
- 12.11.3 Oxford Nanopore Technologies Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.11.4 Oxford Nanopore Technologies Sequencing and Spatial Omics Platform Product Portfolio
- 12.11.5 Oxford Nanopore Technologies Recent Developments
- 12.12 QIAGEN
- 12.12.1 QIAGEN Company Information
- 12.12.2 QIAGEN Business Overview
- 12.12.3 QIAGEN Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.12.4 QIAGEN Sequencing and Spatial Omics Platform Product Portfolio
- 12.12.5 QIAGEN Recent Developments
- 12.13 Miltenyi Biotec
- 12.13.1 Miltenyi Biotec Company Information
- 12.13.2 Miltenyi Biotec Business Overview
- 12.13.3 Miltenyi Biotec Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.13.4 Miltenyi Biotec Sequencing and Spatial Omics Platform Product Portfolio
- 12.13.5 Miltenyi Biotec Recent Developments
- 12.14 MGI Tech
- 12.14.1 MGI Tech Company Information
- 12.14.2 MGI Tech Business Overview
- 12.14.3 MGI Tech Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.14.4 MGI Tech Sequencing and Spatial Omics Platform Product Portfolio
- 12.14.5 MGI Tech Recent Developments
- 12.15 STOmics
- 12.15.1 STOmics Company Information
- 12.15.2 STOmics Business Overview
- 12.15.3 STOmics Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.15.4 STOmics Sequencing and Spatial Omics Platform Product Portfolio
- 12.15.5 STOmics Recent Developments
- 12.16 Novogene
- 12.16.1 Novogene Company Information
- 12.16.2 Novogene Business Overview
- 12.16.3 Novogene Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.16.4 Novogene Sequencing and Spatial Omics Platform Product Portfolio
- 12.16.5 Novogene Recent Developments
- 12.17 Biomarker Technologies
- 12.17.1 Biomarker Technologies Company Information
- 12.17.2 Biomarker Technologies Business Overview
- 12.17.3 Biomarker Technologies Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.17.4 Biomarker Technologies Sequencing and Spatial Omics Platform Product Portfolio
- 12.17.5 Biomarker Technologies Recent Developments
- 12.18 SeekGene
- 12.18.1 SeekGene Company Information
- 12.18.2 SeekGene Business Overview
- 12.18.3 SeekGene Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.18.4 SeekGene Sequencing and Spatial Omics Platform Product Portfolio
- 12.18.5 SeekGene Recent Developments
- 12.19 Takara Bio
- 12.19.1 Takara Bio Company Information
- 12.19.2 Takara Bio Business Overview
- 12.19.3 Takara Bio Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.19.4 Takara Bio Sequencing and Spatial Omics Platform Product Portfolio
- 12.19.5 Takara Bio Recent Developments
- 12.20 Rhelixa
- 12.20.1 Rhelixa Company Information
- 12.20.2 Rhelixa Business Overview
- 12.20.3 Rhelixa Revenue in Sequencing and Spatial Omics Platform Business (2021-2026)
- 12.20.4 Rhelixa Sequencing and Spatial Omics Platform Product Portfolio
- 12.20.5 Rhelixa Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst